ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: Diffuse large B-cell lymphoma (DLBCL), Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)

M. Ghielmini, U. Vitolo, E. Kimby, S. Montoto, J. Walewski, M. Pfreundschuh, M. Federico, P. Hoskin, C. McNamara, F. Caligaris-Cappio, S. Stilgenbauer, R. Marcus, M. Trneny, P. Dreger, E. Montserrat, M. Dreyling

Research output: Contribution to journalArticlepeer-review

Abstract

To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferences to better clarify open issues in each disease. In this setting, a consensus conference on the management of lymphoma was held on 18 June 2011 in Lugano, immediately after the end of the 11th International Conference on Malignant Lymphoma. The consensus conference convened ~45 experts from all around Europe and selected six lymphoma entities to be addressed; for each of them three to five open questions were to be discussed by the experts. For each question, a recommendation should be given by the panel, supported by the strength of the recommendation based on the level of evidence. This consensus report focuses on the three most common lymphoproliferative malignancies: diffuse large B-cell lymphoma, follicular lymphoma and chronic lymphocytic leukemia. A second report will concentrate on mantle cell lymphoma, marginal zone lymphoma and T-cell lymphomas.

Original languageEnglish
Article numbermds517
Pages (from-to)561-576
Number of pages16
JournalAnnals of Oncology
Volume24
Issue number3
DOIs
Publication statusPublished - Mar 2013

Keywords

  • Chronic lymphocytic
  • Consensus conference
  • Diffuse large B-cell lymphoma
  • Follicular lymphoma
  • Leukemia
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Hematology

Fingerprint Dive into the research topics of 'ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: Diffuse large B-cell lymphoma (DLBCL), Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)'. Together they form a unique fingerprint.

Cite this